RH
REGIONAL HEALTH PROPERTIES, INC (RHE)·Q3 2021 Earnings Summary
Executive Summary
- Q3 2021 total revenues were $6.702M vs $6.468M in Q2 and $4.767M in Q3 2020; operating income was $0.628M and net loss was $0.039M, reflecting sequential improvement in operating profit and a narrowed net loss .
- Rent collections remained strong at 97.4%, with a healthy cash balance of $6.233M; management highlighted ongoing efforts to reconfigure the capital structure and confidence in solutions for both classes of equity .
- Refinancing progress: Meadowood loan extended to 2026 and Coosa Valley refinancing reduced cash interest by 155 bps, supporting lower interest burden going forward .
- Portfolio occupancy continued to trend down to 66.7% with skilled mix at 28.8% (12-month basis); rent coverage after management fees improved slightly to 1.23x .
- Wall Street consensus estimates via S&P Global were unavailable for RHE; comparisons vs estimates and beat/miss assessments could not be made [GetEstimates error].
What Went Well and What Went Wrong
What Went Well
- Strong rent collections at 97.4% and healthy liquidity with $6.233M cash; management remains confident about capital structure solutions for both common and preferred holders .
- CEO: “We are proud of our operators and their staff as they work tirelessly to navigate industry headwinds… Our efforts to refigure our capital structure remain on-going and I remain confident we will be able to find a solution for both classes of equity.” CFO: “We’re pleased to have completed the refinancing of two facilities this quarter and four HUD refinancings are expected to be filed in the coming months” .
- Rent coverage after management fees held at 1.23x and before fees at 1.71x on a trailing 12-month basis, indicating resilient tenant performance despite occupancy pressure .
What Went Wrong
- Occupancy declined to 66.7% (12-month basis) with skilled mix at 28.8%, evidencing ongoing census headwinds in the portfolio .
- Patient care economics at the Tara Facility remained pressured: patient care revenues were $2.309M while patient care expenses were $2.454M in Q3 (negative spread) .
- General and administrative expenses rose 30.8% to $1.0M driven by consulting ($0.111M) and stock-based comp ($0.179M); ongoing capital structure costs of ~$0.122M were expensed in other expense, net .
Financial Results
Segment/KPI Breakdown:
Notes:
- “Net loss attributable to common stockholders” includes undeclared preferred dividends and was $(2.289)M in Q3 2021 vs $(2.323)M in Q3 2020; management also disclosed net loss excluding undeclared preferred dividends of $0.039M vs $0.073M in Q3 2020 .
Guidance Changes
Earnings Call Themes & Trends
Note: No Q3 2021 earnings call transcript was available; themes are derived from press releases.
Management Commentary
- CEO Brent Morrison: “We are proud of our operators and their staff as they work tirelessly to navigate industry headwinds. We continue to collect all rent from our operators (outside of a partial rent deferral on one facility). Our efforts to refigure our capital structure remain on-going and I remain confident we will be able to find a solution for both classes of equity.”
- CFO Ben Waites: “We’re pleased to have completed the refinancing of two facilities this quarter and four HUD refinancings are expected to be filed in the coming months.”
- Q2 CEO: “We are pursuing a process to reconfigure the Company’s capital structure… to exchange our Series A Preferred shares for common shares.”
- Q1 CFO: “The opportunities to refinance some of our senior debt… Other capital structure improvements are also underway that should allow the Company to move into a growth mode…”
Q&A Highlights
- No Q3 2021 earnings call transcript was available; no Q&A insights to report [ListDocuments: none].
Estimates Context
- Wall Street consensus estimates via S&P Global (EPS and revenue) were unavailable for RHE for Q3 2021; as a result, we cannot assess beats/misses relative to consensus or infer estimate revisions from S&P Global at this time [GetEstimates error].
Key Takeaways for Investors
- Liquidity and collections resilient: $6.233M cash and 97.4% rent collections support near-term stability amid macro headwinds .
- Sequential improvement in operating income ($0.628M vs $0.548M in Q2) alongside a narrowed net loss ($0.039M vs $(0.503)M in Q2) signals operational progress, though total EPS remains negative .
- Occupancy continues to trend lower (66.7% TTM), pressuring patient care economics at Tara (expenses > revenues in Q3), reinforcing the importance of the new management agreement and incentive-based EBITDAR thresholds with Peach Health .
- Debt actions are tangible catalysts: Meadowood extended to 2026 and Coosa Valley interest reduced by 155 bps; additional HUD filings expected, which should help reduce interest burden and extend maturities .
- Preferred equity overhang and capital structure reconfiguration remain central to the equity narrative; management engagement with the SEC and investors continues, but timing remains uncertain .
- Without S&P Global consensus coverage, traders should anchor on sequential trends (revenues, operating income, collections) and debt-refinancing milestones for near-term stock reaction catalysts .
- Monitoring: watch occupancy and skilled mix stabilization, execution on HUD refinancings, and any formal guidance or capital structure transaction updates for re-rating potential .